Cargando…
Behavioral and slice electrophysiological assessment of DREADD ligand, deschloroclozapine (DCZ) in rats
Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) have become a premier neuroscience research tool for enabling reversible manipulations of cellular activity following experimenter-controlled delivery of a DREADD-specific ligand. However, several DREADD ligands, e.g., clozapine-N-...
Autores principales: | Nentwig, Todd B., Obray, J. Daniel, Vaughan, Dylan T., Chandler, L. Judson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023443/ https://www.ncbi.nlm.nih.gov/pubmed/35449195 http://dx.doi.org/10.1038/s41598-022-10668-0 |
Ejemplares similares
-
The Use of DREADDs to Deconstruct Behavior
por: Whissell, Paul D., et al.
Publicado: (2016) -
High-potency ligands for DREADD imaging and activation in rodents and monkeys
por: Bonaventura, Jordi, et al.
Publicado: (2019) -
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based
DREADDs in Vitro and in Vivo
por: Thompson, Karen J., et al.
Publicado: (2018) -
The use of chemogenetic actuator ligands in nonhuman primate DREADDs-fMRI
por: Cushnie, Adriana K., et al.
Publicado: (2022) -
Eye-Drops for Activation of DREADDs
por: Keenan, William T., et al.
Publicado: (2017)